Treatment preferences for preventive interventions for rheumatoid arthritis: protocol of a mixed methods case study for the Innovative Medicines Initiative PREFER project.

Marie FalaheeGwenda SimonsRachael L DiSantostefanoLarissa Valor MéndezChristine RadawskiMatthias EnglbrechtKarin Schölin BywallStephanie Tcherny-LessenotUlrik KihlbomBrett HauberJorien VeldwijkKarim Raza

Published in: BMJ open (2021)

This study has been approved by the London-Hampstead Research Ethics Committee (19/LO/0407) and the Ethics Committee of the Friedrich-Alexander-Universität Erlangen-Nürnberg (92_17 B). The protocol has been approved by the PREFER expert review board. The results will be disseminated widely and will inform the PREFER recommendations.

Keyphrases

rheumatoid arthritis
quality improvement
public health
randomized controlled trial
big data
clinical practice
drug administration
physical activity
disease activity
decision making
interstitial lung disease
systemic lupus erythematosus
artificial intelligence